CNTB Connect Biopharma Holdings Limited - Ordinary Shares
$2,54
Precio · Ago 19, 2026
Fundamentales a fecha de Ago 12, 2026
Rango 52S
$1–$4
50% of range
Calificación del Analista
BUY
14 analysts
Precio Objetivo
$7
+186% upside
P/E (TTM)
-2.8
ROE
-97.9%
Margen de Beneficio Neto
-86687.5%
CNTB Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$2.54
Capitalización Bursátil
$159M
P/E (TTM)
-2.8
BPA (TTM)
$-1.00
Ingresos (TTM)
$64.0K
Rendimiento div.
—
ROE
-97.9%
Deuda/Capital
—
Rango 52S
$1 – $4
CNTB Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
Configure
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos y Beneficio Neto
$64.0K
2023-12-31
→
2025-12-31
BPA
$-1.00
2023-12-31
→
2025-12-31
Flujo de caja libre
$-52M
2024-12-31
→
2025-12-31
Márgenes
-86687.5%
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
Métrica
Tendencia a 5 años
CNTB
Mediana de Pares
P/E (TTM)
-2.8
1.2
P/S (TTM) (P/V (TTM))
2484.0
14.2
P/B (P/C)
3.8
1.2
Price / FCF (Precio / FCF)
-3.1
—
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
Métrica
Tendencia a 5 años
CNTB
Mediana de Pares
Operating Margin (Margen Operativo)
-90740.6%
—
Net Profit Margin (Margen de Beneficio Neto)
-86687.5%
-1189.1%
ROA
-70.5%
-58.9%
ROE
-97.9%
-79.0%
ROIC
-138.8%
—
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
Métrica
Tendencia a 5 años
CNTB
Mediana de Pares
Current Ratio (Ratio corriente)
3.7
5.4
Quick Ratio (Ratio Rápido)
3.3
—
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Métrica
Tendencia a 5 años
CNTB
Mediana de Pares
Revenue YoY (Ingresos interanuales)
-99.8%
—
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
Métrica
Tendencia a 5 años
CNTB
Mediana de Pares
CNTB Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
COMPRA
14 analistas
- Compra fuerte 5 35,7%
- Compra 8 57,1%
- Mantener 1 7,1%
- Venta 0 0,0%
- Venta fuerte 0 0,0%
Precio objetivo a 12 meses
8 analistas · 2026-08-17
Mediana
$7.00
← Por Debajo de Todos los Objetivos
$2.54
Mín
$4.00
Máx
$10.00
Objetivo mediano
$7.00
+176,1%
Objetivo medio
$7.25
+186,0%
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
1.0%
| Período | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|
| 31 de marzo de 2026 | $-0.34 | $-0.23 | -0.11% |
| 31 de diciembre de 2025 | $-0.27 | $-0.21 | -0.06% |
| 30 de septiembre de 2025 | $-0.31 | $-1.01 | 0.70% |
| 30 de junio de 2025 | $-0.23 | $-0.92 | 0.69% |
| 31 de marzo de 2025 | $-0.19 | $-1.92 | 1.7% |
| 30 de junio de 2023 | $-3.90 | $-7.07 | 3.2% |
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| CNTB | $159M | -2.8 | -99.8% | -86687.5% | -97.9% | — |
| NKTX | $131M | -1.3 | — | — | -31.1% | — |
| OKUR | — | -0.7 | — | -1733.7% | -88.6% | — |
| CRBU | $151M | -1.0 | 11.7% | -1327.4% | -102.8% | — |
| TNYA | $154M | -1.2 | — | — | -81.2% | — |
| CNTN | $112M | -2.7 | — | — | -18.0% | — |
| HUMA | — | — | — | — | — | — |
| UNCY | $128M | -3.5 | -29.0% | — | -113.9% | — |
| EQ | $95M | -4.0 | 13.9% | — | -133.1% | — |
| HURA | — | -1.2 | — | — | — | — |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados 14
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue | $64.0K | $26M | $0 | |
| R&D Expense | $38M | $29M | $53M | |
| SG&A Expense | $20M | $19M | $16M | |
| Operating Expenses | $58M | $48M | $69M | |
| Operating Income | $-58M | $-22M | $-69M | |
| Other Non-op | $523.0K | $3M | $2M | |
| Pretax Income | $-55M | $-15M | $-62M | |
| Income Tax | $197.0K | $223.0K | $120.0K | |
| Net Income | $-55M | $-16M | $-62M | |
| EPS (Basic) | $-1.00 | $-0.28 | $-1.13 | |
| EPS (Diluted) | $-1.00 | $-0.28 | $-1.13 | |
| Shares (Basic) | 55,660,000 | 55,213,000 | 55,067,000 | |
| Shares (Diluted) | 55,660,000 | 55,213,000 | 55,067,000 | |
| EBITDA | $-57M | $-22M | · |
Balance general 26
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $38M | $78M | $106M | |
| Short-term Investments | $6M | $15M | $13M | |
| Receivables | $13.0K | $789.0K | $0 | |
| Prepaid Expense | $7M | $2M | $4M | |
| Other Current Assets | · | $53.0K | $54.0K | |
| Current Assets | $51M | $97M | $123M | |
| PP&E (Net) | $4M | $4M | $4M | |
| PP&E (Gross) | $7M | $7M | $6M | |
| Accum. Depreciation | $3M | $3M | $2M | |
| Intangibles | $45.0K | $53.0K | $62.0K | |
| Other Non-current Assets | $646.0K | $33.0K | $24.0K | |
| Total Assets | $56M | $101M | $127M | |
| Accounts Payable | $2M | $342.0K | $2M | |
| Accrued Liabilities | $11M | $8M | $9M | |
| Current Liabilities | $14M | $8M | $25M | |
| Capital Leases | $368.0K | $24.0K | $180.0K | |
| Other Non-current Liabilities | $114.0K | $632.0K | · | |
| Total Liabilities | $14M | $9M | $26M | |
| Common Stock | $10.0K | $10.0K | $10.0K | |
| Paid-in Capital | $444M | $439M | $432M | |
| Retained Earnings | $-401M | $-345M | $-330M | |
| Treasury Stock | $180.0K | $180.0K | $180.0K | |
| AOCI | $-1M | $-2M | $-1M | |
| Stockholders' Equity | $42M | $92M | $101M | |
| Liabilities + Equity | $56M | $101M | $127M | |
| Shares Outstanding | 56,442,308 | 55,349,000 | 55,103,000 |
Flujo de Efectivo 11
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| D&A | $704.0K | $660.0K | $720.0K | |
| Stock-based Comp | $4M | $7M | $5M | |
| Restructuring | · | $3M | · | |
| Other Non-cash | $-156.0K | $-15M | · | |
| Operating Cash Flow | $-51M | $-24M | $-48M | |
| CapEx | $434.0K | $750.0K | $81.0K | |
| Investing Cash Flow | $10M | $-3M | $75M | |
| Financing Cash Flow | $1M | $227.0K | $45.0K | |
| Net Change in Cash | $-40M | $-27M | $27M | |
| Taxes Paid | · | $111.0K | $120.0K | |
| Free Cash Flow | $-52M | $-24M | · |
Rentabilidad 7
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Operating Margin | -90740.6% | -86.2% | · | |
| Net Margin | -86687.5% | -60.0% | · | |
| Pretax Margin | -86379.7% | -59.2% | · | |
| EBITDA Margin | -89640.6% | -83.7% | · | |
| ROA | -70.5% | -13.7% | · | |
| ROE | -97.9% | -16.2% | · | |
| ROIC | -138.8% | -24.7% | · |
Liquidez y Solvencia 2
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Current Ratio | 3.7 | 11.5 | · | |
| Quick Ratio | 3.3 | 11.2 | · |
Eficiencia 2
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.2 | · | |
| Receivables Turnover | 0.2 | 66.0 | · |
Tasas de Crecimiento 1
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue YoY | -99.8% | · | · |
Valoración (TTM) 10
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue TTM | $64.0K | $26M | · | |
| Net Income TTM | $-55M | $-16M | · | |
| Market Cap | $159M | $76M | · | |
| P/E | -2.8 | -4.9 | · | |
| P/S | 2487.0 | 2.9 | · | |
| P/B | 3.8 | 0.8 | · | |
| P / Tangible Book | 3.8 | 0.8 | · | |
| P / Cash Flow | -3.1 | -3.2 | · | |
| P / FCF | -3.1 | -3.1 | · | |
| Earnings Yield | -35.5% | -20.3% | · |
Estado de resultados 14
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3M | $169.0K | $0 | $16.0K | $48.0K | $0 | $698.0K | $1M | $24M | |
| R&D Expense | $16M | $15M | $11M | $11M | $9M | $7M | $6M | $9M | $5M | |
| SG&A Expense | $4M | $5M | $4M | $7M | $5M | $5M | $4M | $6M | $5M | |
| Operating Expenses | $20M | $20M | $16M | $18M | $13M | $11M | $10M | $15M | $10M | |
| Operating Income | $-18M | $-20M | $-16M | $-18M | $-13M | $-11M | $-10M | $-14M | $14M | |
| Other Non-op | $67.0K | $-3.0K | $60.0K | $-7.0K | $-39.0K | $509.0K | $-30.0K | $-108.0K | $9.0K | |
| Pretax Income | $-17M | $-19M | $-15M | $-17M | $-13M | $-10M | $-9M | $-13M | $15M | |
| Income Tax | $60.0K | $48.0K | $27.0K | $61.0K | $55.0K | $54.0K | $106.0K | $57.0K | $30.0K | |
| Net Income | $-17M | $-19M | $-15M | $-17M | $-13M | $-10M | $-9M | $-13M | $15M | |
| EPS (Basic) | $-0.27 | $-0.34 | $-0.27 | $-0.31 | $-0.23 | $-0.19 | $-0.16 | $-0.23 | $0.27 | |
| EPS (Diluted) | $-0.27 | $-0.34 | $-0.27 | $-0.31 | $-0.23 | $-0.19 | $-0.16 | $-0.23 | $0.27 | |
| Shares (Basic) | 62,884,000 | 56,545,000 | -110,906,000 | 55,716,000 | 55,498,000 | 55,352,000 | -110,330,000 | 55,254,000 | 55,186,000 | |
| Shares (Diluted) | 62,884,000 | 56,545,000 | -110,906,000 | 55,716,000 | 55,498,000 | 55,352,000 | -110,854,000 | 55,254,000 | 55,710,000 | |
| EBITDA | $-18M | $-19M | · | $-18M | $-13M | $-11M | · | · | · |
Balance general 26
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $27M | $46M | $38M | $38M | $41M | $48M | $78M | · | · | |
| Short-term Investments | $4M | $0 | $6M | $17M | $31M | $36M | $15M | · | · | |
| Receivables | $3M | $0 | $13.0K | $17.0K | $0 | $8.0K | $789.0K | · | · | |
| Prepaid Expense | $4M | $9M | $7M | $8M | $6M | $4M | $2M | · | · | |
| Other Current Assets | · | · | · | · | $228.0K | $65.0K | · | · | · | |
| Current Assets | $39M | $55M | $51M | $63M | $78M | $88M | $97M | · | · | |
| PP&E (Net) | $4M | $4M | $4M | $4M | $4M | $4M | $4M | · | · | |
| PP&E (Gross) | · | · | $7M | · | · | · | $7M | · | · | |
| Accum. Depreciation | · | · | $3M | · | · | · | $3M | · | · | |
| Intangibles | $42.0K | $43.0K | $45.0K | $47.0K | $48.0K | $50.0K | $53.0K | · | · | |
| Other Non-current Assets | $646.0K | $646.0K | $646.0K | $45.0K | $45.0K | $45.0K | $33.0K | · | · | |
| Total Assets | $43M | $60M | $56M | $67M | $83M | $93M | $101M | · | · | |
| Accounts Payable | $2M | $4M | $2M | $2M | $2M | $817.0K | $342.0K | · | · | |
| Accrued Liabilities | $14M | $12M | $11M | $9M | $8M | $7M | $8M | · | · | |
| Current Liabilities | $16M | $17M | $14M | $11M | $11M | $9M | $8M | · | · | |
| Capital Leases | $203.0K | $287.0K | $368.0K | $445.0K | $520.0K | $594.0K | $24.0K | · | · | |
| Other Non-current Liabilities | $107.0K | $111.0K | $114.0K | $118.0K | $122.0K | $627.0K | $632.0K | · | · | |
| Total Liabilities | $17M | $17M | $14M | $12M | $11M | $10M | $9M | · | · | |
| Common Stock | $11.0K | $11.0K | $10.0K | $10.0K | $10.0K | $10.0K | $10.0K | · | · | |
| Paid-in Capital | $466M | $464M | $444M | $443M | $441M | $440M | $439M | · | · | |
| Retained Earnings | $-438M | $-420M | $-401M | $-386M | $-369M | $-356M | $-345M | · | · | |
| Treasury Stock | $180.0K | $180.0K | $180.0K | $180.0K | $180.0K | $180.0K | $180.0K | · | · | |
| AOCI | $-962.0K | $-1M | $-1M | $-1M | $-1M | $-2M | $-2M | · | · | |
| Stockholders' Equity | $27M | $43M | $42M | $55M | $71M | $83M | $92M | · | · | |
| Liabilities + Equity | $43M | $60M | $56M | $67M | $83M | $93M | $101M | · | · | |
| Shares Outstanding | 62,974,309 | 62,711,690 | 56,442,308 | 55,786,000 | 55,580,000 | 55,352,000 | 55,349,208 | · | · |
Flujo de Efectivo 13
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $161.0K | $164.0K | $181.0K | $179.0K | $171.0K | $173.0K | $158.0K | $176.0K | $162.0K | |
| Stock-based Comp | $1M | $1M | $917.0K | $916.0K | $951.0K | $942.0K | $1M | $2M | $2M | |
| Restructuring | · | · | · | · | · | · | $0 | $2M | $1M | |
| Other Non-cash | · | $2M | · | · | · | $-802.0K | · | · | · | |
| Operating Cash Flow | $-16M | $-16M | $-11M | $-17M | $-13M | $-10M | $-2M | $-13M | $-8M | |
| CapEx | $0 | $0 | $16.0K | $34.0K | $303.0K | $81.0K | $313.0K | $147.0K | $290.0K | |
| Investing Cash Flow | $-4M | $6M | $11M | $14M | $5M | $-21M | $-16M | $-147.0K | $3M | |
| Stock Issued | $0 | $137.0K | · | · | $18.0K | $2.0K | · | · | · | |
| Net Stock Activity | · | $137.0K | · | · | · | · | · | · | · | |
| Financing Cash Flow | $1M | $18M | $715.0K | $215.0K | $161.0K | $2.0K | $106.0K | $0 | $121.0K | |
| Net Change in Cash | $-19M | $8M | $500.0K | $-3M | $-7M | $-31M | $-19M | $-13M | $-4M | |
| Taxes Paid | · | · | · | $0 | · | · | · | $111.0K | · | |
| Free Cash Flow | · | $-16M | · | · | · | $-10M | · | · | · |
Rentabilidad 7
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -636.0% | -11601.8% | · | -110481.2% | -27966.7% | · | · | · | · | |
| Net Margin | -624.4% | -11478.1% | · | -107500.0% | -26872.9% | · | · | · | · | |
| Pretax Margin | -622.2% | -11449.7% | · | -107118.8% | -26758.3% | · | · | · | · | |
| EBITDA Margin | -636.0% | -11504.7% | · | -110481.2% | -27966.7% | · | · | · | · | |
| ROA | -27.4% | -25.4% | · | -51.1% | -31.2% | -22.2% | · | · | · | |
| ROE | -35.2% | -30.9% | · | -62.1% | -36.2% | -24.8% | · | · | · | |
| ROIC | -65.8% | -46.1% | · | -32.0% | -18.9% | -13.9% | · | · | · |
Liquidez y Solvencia 2
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.4 | 3.2 | · | 5.5 | 7.2 | 10.2 | · | · | · | |
| Quick Ratio | 2.1 | 2.7 | · | 4.8 | 6.7 | 9.8 | · | · | · |
Eficiencia 2
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | · | · | · | · | |
| Receivables Turnover | 1.9 | 42.2 | · | 1.9 | · | · | · | · | · |
Valoración (TTM) 10
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $3M | $233.0K | · | · | · | · | · | · | · | |
| Net Income TTM | $-67M | $-60M | · | $-53M | $-21M | $-17M | · | · | · | |
| Market Cap | $150M | $164M | · | $84M | $54M | $30M | · | · | · | |
| P/E | -2.1 | -2.4 | · | -1.6 | -2.6 | -1.8 | · | · | · | |
| P/S | 49.9 | 705.2 | · | · | · | · | · | · | · | |
| P/B | 5.6 | 3.9 | · | 1.5 | 0.8 | 0.4 | · | · | · | |
| P / Tangible Book | 5.6 | 3.9 | · | 1.5 | 0.8 | 0.4 | · | · | · | |
| P / Cash Flow | · | -10.3 | · | · | · | -3.1 | · | · | · | |
| P / FCF | · | -10.3 | · | · | · | -3.0 | · | · | · | |
| Earnings Yield | -48.3% | -40.8% | · | -63.6% | -38.8% | -56.4% | · | · | · |
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
Estado de resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Ingresos | $64.0K | $26M | $0 |
| Margen Operativo % | -90740.6% | -86.2% | — |
| Beneficio neto | $-55M | $-16M | $-62M |
| EPS Diluido | $-1.00 | $-0.28 | $-1.13 |
Balance general
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Ratio corriente | 3.7 | 11.5 | — |
| Ratio Rápido | 3.3 | 11.2 | — |
Flujo de Efectivo
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Flujo de caja libre | $-52M | $-24M | — |
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
📊
Elige las métricas que te importan — haz clic en el ➕ junto a cualquier fila en Fundamentales Completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Propietarios institucionales (13F) 56 declarantes · $29.2M total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 24 (+4 vs trimestre anterior) | 9 (+6 vs trimestre anterior) | 14 (+7 vs trimestre anterior) | 11 (+4 vs trimestre anterior) | -260K |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| Ikarian Capital, LLC | $10 801 710 | 4 538 534 | 36,96% | Acciones |
| 683 Capital Management, LLC | $3 058 300 | 1 285 000 | 10,46% | Acciones |
| BOOTHBAY FUND MANAGEMENT, LLC | $2 317 482 | 973 732 | 7,93% | Acciones |
| PERCEPTIVE ADVISORS LLC | $1 886 616 | 792 696 | 6,45% | Acciones |
| ADAR1 Capital Management, LLC | $1 666 000 | 700 000 | 5,70% | Acciones |
| BML Capital Management, LLC | $1 364 423 | 573 287 | 4,67% | Acciones |
| SILVERARC CAPITAL MANAGEMENT, LLC | $1 297 100 | 545 000 | 4,44% | Acciones |
| Knott David M Jr | $1 058 772 | 444 862 | 3,62% | Acciones |
| Stonepine Capital Management, LLC | $866 925 | 364 254 | 2,97% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $561 099 | 235 756 | 1,92% | Acciones |
| TWO SIGMA INVESTMENTS, LP | $474 527 | 199 381 | 1,62% | Acciones |
| DIADEMA PARTNERS LP | $468 824 | 196 985 | 1,60% | Acciones |
| MARSHALL WACE, LLP | $388 341 | 163 168 | 1,33% | Acciones |
| Burkehill Global Management, LP | $357 000 | 150 000 | 1,22% | Acciones |
| Richmond Brothers, Inc. | $334 169 | 140 408 | 1,14% | Acciones |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $244 557 | 102 755 | 0,84% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $243 112 | 102 148 | 0,83% | Acciones |
| RENAISSANCE TECHNOLOGIES LLC | $207 774 | 87 300 | 0,71% | Acciones |
| SIMPLEX TRADING, LLC | $195 036 | 81 948 | 0,67% | Acciones |
| STATE STREET CORP | $158 746 | 66 700 | 0,54% | Acciones |
| UBS Group AG | $158 153 | 66 451 | 0,54% | Acciones |
| Persistent Asset Partners Ltd | $118 698 | 49 873 | 0,41% | Acciones |
| Koa Wealth Management, LLC | $118 048 | 49 600 | 0,40% | Acciones |
| NEW YORK STATE COMMON RETIREMENT FUND | $115 192 | 48 400 | 0,39% | Acciones |
| MILLENNIUM MANAGEMENT LLC | $104 025 | 43 708 | 0,36% | Acciones |
| BANK OF AMERICA CORP /DE/ | $97 390 | 40 920 | 0,33% | Acciones |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $87 489 | 36 760 | 0,30% | Acciones |
| XTX Topco Ltd | $68 208 | 28 659 | 0,23% | Acciones |
| Bank of New York Mellon Corp | $57 006 | 23 952 | 0,20% | Acciones |
| Nuveen, LLC | $47 060 | 19 773 | 0,16% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $43 554 | 18 300 | 0,15% | Opción de venta |
| Y-Intercept (Hong Kong) Ltd | $35 864 | 15 069 | 0,12% | Acciones |
| WELLS FARGO & COMPANY/MN | $31 511 | 13 240 | 0,11% | Acciones |
| SmartHarvest Portfolios, LLC | $30 695 | 12 897 | 0,11% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $26 927 | 11 314 | 0,09% | Acciones |
| MONOGRAPH WEALTH ADVISORS, LLC | $26 489 | 11 130 | 0,09% | Acciones |
| RHUMBLINE ADVISERS | $26 124 | 10 979 | 0,09% | Acciones |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $16 432 | 6 904 | 0,06% | Acciones |
| JPMORGAN CHASE & CO | $14 794 | 6 216 | 0,05% | Acciones |
| CITIGROUP INC | $14 568 | 6 121 | 0,05% | Acciones |
| Legal & General Group Plc | $5 748 | 2 415 | 0,02% | Acciones |
| NORTHERN TRUST CORP | $5 693 | 2 392 | 0,02% | Acciones |
| MORGAN STANLEY | $5 622 | 2 362 | 0,02% | Acciones |
| BNP PARIBAS FINANCIAL MARKETS | $5 450 | 2 290 | 0,02% | Acciones |
| BARCLAYS PLC | $4 698 | 1 974 | 0,02% | Acciones |
| Russell Investments Group, Ltd. | $2 844 | 1 195 | 0,01% | Acciones |
| BlackRock, Inc. | $2 509 | 1 054 | 0,01% | Acciones |
| HUNTINGTON NATIONAL BANK | $2 370 | 996 | 0,01% | Acciones |
| Tower Research Capital LLC (TRC) | $2 099 | 882 | 0,01% | Acciones |
| ROYAL BANK OF CANADA | $1 000 | 540 | 0,00% | Acciones |
| FMR LLC | $747 | 314 | 0,00% | Acciones |
| Sterling Capital Management LLC | $357 | 150 | 0,00% | Acciones |
| Caitong International Asset Management Co., Ltd | $157 | 66 | 0,00% | Acciones |
| PRICE T ROWE ASSOCIATES INC /MD/ | $30 | 12 469 | 0,00% | Acciones |
| SBI Securities Co., Ltd. | $14 | 6 | 0,00% | Acciones |
| FNY Investment Advisers, LLC | $11 | 5 000 | 0,00% | Acciones |
Informantes de la empresa 3 insiders · 0 directivos · 3 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Kleanthis Gabriel Xanthopoulos | Consejero | 30 de junio de 2026 A | 86 554 | 0 | 0 | $0 |
| Jean I Liu | Consejero | 30 de junio de 2026 A | 11 779 | 0 | 0 | $0 |
| James Huang | Consejero | 29 de mayo de 2026 P | 13 310 000 | 2 | 0 | $4 374 000 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Activistas y propietarios del %+ 5 2 tenencias
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| Panacea Innovation Limited, Panacea Venture Healthcare Fund II, L.P., Panacea Venture Healthcare Fund II GP Company, Ltd., James Huang ×6 presentaciones | 1 de abril de 2026 | 21,20% | Enmienda | — | SEC |
| RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, RA Capital Healthcare Fund, L.P. ×6 presentaciones | 27 de febrero de 2024 | — | Presentación inicial | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Propiedad de ETFs Mantenido por 6 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| IWC · iShares Trust | 0,01% | 50 108 SH | 8 de agosto de 2026 | Diario |
| IWO · iShares Trust | 0,01% | 370 406 SH | 8 de agosto de 2026 | Diario |
| IWM · iShares Trust | 0,00% | 376 234 SH | 8 de agosto de 2026 | Diario |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,00% | 86 692 SH | 8 de agosto de 2026 | Diario |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,00% | 6 283 SH | 8 de agosto de 2026 | Diario |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,00% | 9 780 SH | 8 de agosto de 2026 | Diario |